The Pharmacists' Syndicate in Syria said that most chronic disease medicines, particularly those for hypertension and diabetes, are currently available in pharmacies, and that the national pharmaceutical industry covers the largest share of local market needs. However, the syndicate pointed to shortages and stock-outs of some specialized and imported items.
The syndicate said the shortages particularly affect hormonal and glandular medicines and some types of insulin, in addition to oncology and immunology drugs. It noted that pharmacies are recording repeated shortages affecting more than fifty imported pharmaceutical preparations, despite the Ministry of Health's efforts to secure them within available means. It explained that, through its central medicine warehouse, it has begun taking steps to secure a number of the missing items and meet patients' needs.
Drug Alternatives and How to Search for Medicine
The syndicate stressed the need to distinguish between replacing a medicine's brand name and replacing its active ingredient. It explained that a pharmacist can guide the patient to a commercial alternative identical in active ingredient, within professional and legal rules, and within the scope of medicines that may be dispensed without a prescription. Critical health cases, or those requiring a change of active ingredient or an adjustment of dose, require consulting the specialist doctor.
Regarding searching for a medicine that is unavailable at a particular pharmacy, the syndicate pointed to a wide network of pharmacies in cities and rural areas, linked by professional communication channels that allow inquiring about missing items and directing the patient to the nearest pharmacy where the medicine is available. It also noted the existence of central pharmacies belonging to the syndicate's branches in the governorates, which work to secure pharmaceutical items and make them available to patients.
The syndicate warned against abruptly stopping chronic disease medicines, particularly those for blood pressure, epilepsy and psychiatric conditions, and stressed the need to refer the patient to their specialist doctor when a medicine is unavailable, in order to adjust the treatment plan or prescribe a suitable alternative.
Doctors Warn of the Risks of Interrupted Treatment
For his part, Dr. Ghassan Tamer explained that the danger of interrupted treatment varies with the type of disease and medicine. He noted that a diabetic patient who stops using insulin may suffer a severe rise in blood sugar levels, while interruption of blood pressure and heart medicines leads to loss of control over the disease. He added that stopping epilepsy medicines may cause recurring seizures, and that suddenly stopping cortisone after long-term use may lead to adrenal insufficiency.
Tamer stressed that replacing a medicine should not be done randomly, explaining that a pharmacist can provide an equivalent alternative containing the same active ingredient, concentration and pharmaceutical form, according to approved rules. Changing the active ingredient, dose or treatment plan requires medical assessment, especially with heart, epilepsy and diabetes medicines and blood thinners.
In a related context, Dr. Ahmed al-Ali stressed the importance of acting early when a medicine is expected to run out, urging patients to contact their doctor and pharmacist before their available supply ends. He advised looking for approved alternatives through pharmacies and health centers, keeping the prescription and medical report, and avoiding reducing doses or splitting tablets to prolong the treatment period. He added that when a medicine cannot be obtained, an alternative treatment plan should be requested from the doctor without delay, warning against ignoring symptoms that may indicate serious complications.
Al-Ali identified the cases requiring urgent medical intervention as chest pain, shortness of breath and fainting, sudden disturbance in speech or vision, high blood sugar accompanied by vomiting or impaired consciousness, as well as repeated epileptic seizures or seizures lasting five minutes or more, and severe bleeding or symptoms of clots.
National Awareness Campaign
On the awareness front, the Ministry of Health, in cooperation with the World Health Organization, launched on September 17 a national campaign marking World Patient Safety Day, which lasted a week and covered all Syrian governorates. The campaign focused on promoting health awareness and encouraging early detection and adherence to treatment, with particular attention to chronic diseases, foremost heart disease, hypertension and diabetes, as well as neurological diseases such as multiple sclerosis.
The campaign's activities included organizing sports events for patients and measuring vital signs, alongside awareness activities aimed at reaching as many patients as possible and promoting healthy and preventive practices.
Recommendations
The clarifications provided stress that patients should not be left to deal with a medicine shortage through personal judgment, whether by stopping treatment, changing doses or using unapproved alternatives. Early contact with the doctor and pharmacist, organized searching for the medicine, and drawing up an alternative treatment plan when necessary remain essential steps to limit complications and keep patients stable.
Source: Syrian Arab News Agency (SANA)

Comments (0)